Filing Details
- Accession Number:
- 0001225208-17-018485
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-11 16:38:45
- Reporting Period:
- 2017-12-07
- Accepted Time:
- 2017-12-11 16:38:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1666700 | Dowdupont Inc. | DWDP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1269971 | N Andrew Liveris | C/O The Dow Chemical Company 2030 Dow Center Midland MI 48674 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-07 | 4,912 | $38.62 | 654,848 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-07 | 4,912 | $71.50 | 649,936 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-12-08 | 24,811 | $38.62 | 674,747 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-08 | 24,811 | $71.50 | 649,936 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-12-07 | 4,912 | $38.62 | 4,912 | $38.62 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-12-08 | 24,811 | $38.62 | 24,811 | $38.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 277,056 | 2018-02-15 | No | 4 | M | Direct | |
| 252,245 | 2018-02-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,719 | Indirect | By 401(k) Plan |
| Common Stock | 3,668 | Indirect | By 401(k) Plan ESOP |
| Common Stock | 682,825 | Indirect | By Trust |
Footnotes
- The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- All sales occurred at a price of $71.50.
- The price represents the weighted average sale price. All sales occurred at a range of $71.50 to $71.52.
- Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights.
- The options vested in three annual installments beginning on February 15, 2009.
Billionaire Hedge Funds
